Intuitive Surgical director sells 20,095 shares
The director's reported sale was made under a Rule 10b5-1 Trading Plan that expires June 15, 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Intuitive Surgical (ISRG) director Gary S. Guthart reported the sale of 20,095 shares held indirectly by a Trust on October 23, 2026, at a weighted average sale price of $451.6117 per share. The reported post-sale position held through a Trust was 1,204,530 shares. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2027. The reported indirect holdings also included 26,247 shares in a Trust FBO Daughter and 26,247 shares in a Trust FBO Son.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 20,095 | $451.6117 | $9.08M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2027.
- F2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $444.04 to $458.10 as follows: 120 shares sold at $444.04 to $444.43; 240 shares sold at $445.55 to $446.21; 200 shares sold at $446.78 to $447.34; 320 shares sold at $448.00 to $448.91; 10,360 shares sold at $449.04 to $450.02; 160 shares sold at $450.13 to $450.44; 840 shares sold at $451.20 to $452.19; 3,577 shares sold at $452.20 to $453.17; 908 shares sold at $453.20 to $454.11; 702 shares sold at $454.33 to $455.32; 988 shares sold at $455.34 to $456.32; 960 shares sold at $456.36 to $457.28; and 720 shares sold at $457.36 to $458.10 The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Key Figures
Key Terms
Trading Plan regulatory
SEC Rule 10b5-1 regulatory
weighted average sale price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.